Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531
Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531
Arlene Naranjo, Wendy B. London, John M. Maris, Dave R. Lal et al.
Citations
5 citations
Journal
Journal of Pediatric Surgery
Topics
Neuroblastoma Research and Treatments
Field-Weighted Citation Impact (FWCI)
1.85
article
Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531
Arlene Naranjo, Wendy B. London, John M. Maris, Dave R. Lal, Julie R. Park, Erin G. Brown, Peter Mattei, Clare J. Twist, Erika A. Newman, Susan L. Cohn, Rochelle Bagatell, Meredith S. Irwin, Michael D. Hogarty, Jed G. Nuchtern, Andrew M. Davidoff, Fredric A. Hoffer, Mary Lou Schmidt, Sandra L. Wootton‐Gorges, E. Stanton Adkins
article en
5 citations
Abstract
No abstract available for this paper.
Publication Tag
Journal of Pediatric SurgeryVol. 60(1)
Institutions
Children's Oncology Group (CH), Children's Hospital of Wisconsin (US), Roswell Park Comprehensive Cancer Center (US), St. Jude Children's Research Hospital (US), Children's Hospital of Philadelphia (US), University of South Carolina (US), University of Washington (US), Hospital for Sick Children (CA), University of Illinois Chicago (US), University of Chicago (US), University of Chicago Medical Center (US), Dana-Farber Cancer Institute (US), Children's Oncology Group (US), Texas Children's Hospital (US), C. S. Mott Children's Hospital (US), UC Davis Children's Hospital (US)
Funders
National Institutes of Health, National Cancer Institute